Ignite Creation Date:
2025-12-24 @ 5:10 PM
Ignite Modification Date:
2026-01-31 @ 5:36 AM
Study NCT ID:
NCT01260350
Status:
COMPLETED
Last Update Posted:
2014-11-17
First Post:
2010-12-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3
Sponsor:
Gilead Sciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Hepatitis C Infection | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | PSI-7977 | View |
| None | Sofosbuvir | View |
| None | GS-7977 | View |
| None | GS-5885 | View |
| None | GS-9669 | View |
| None | FDC | View |
| None | ribavirin | View |
| None | RBV | View |
| None | Pegylated Interferon | View |
| None | PEG-IFN | View |
| None | Chronic Hepatitis C Infection | View |
| None | HCV | View |
| None | Hepatitis | View |
| None | Genotype 1 | View |
| None | Genotype 2 | View |
| None | Genotype 3 | View |
| None | GT 1 | View |
| None | GT 2 | View |
| None | GT 3 | View |
| None | Hemophilia | View |